In an analysis that included nearly 300,000 patients from eight states who underwent ambulatory surgery, researchers found that the rates of surgical site infections were relatively low; however, the absolute number of patients with these complications is substantial, according to a study in the February 19 issue of JAMA.
Â
Surgical site infections are among the most common healthcare-associated infections, accounting for 20 percent to 31 percent of healthcare-associated infections in hospitalized patients, according to background information in the article. Although ambulatory surgeries represent a substantial portion of surgical healthcare, there is a lack of information on adverse events, including healthcare-associated infections.
Â
Pamela L. Owens, PhD, of the Agency for Healthcare Research and Quality (AHRQ) in Rockville, Md., and colleagues determined the incidence of clinically significant surgical site infections (CS-SSIs) following low- to moderate-risk ambulatory surgery in patients with low risk for surgical complications (defined as not seen in past 30 days in acute care, length of stay less than two days, no other surgery on the same day, and discharged home and no infection coded on the same day). The researchers used the 2010 Healthcare Cost and Utilization Project State Ambulatory Surgery and State Inpatient Databases for eight states (California, Florida, Georgia. Hawaii. Missouri, Nebraska, New York, and Tennessee), representing one-third of the U.S. population. The analysis included 284,098 ambulatory surgical procedures (general surgery, orthopedic, neurosurgical, gynecologic, and urologic) in adult patients; rates were calculated for 14- and 30-day postsurgical acute care visits for CS-SSIs following ambulatory surgery.
Â
The researchers found that the overall rate of postsurgical acute care visits within 14 days for CS-SSIs was relatively low (3.09 per 1,000 ambulatory surgical procedures). When the time frame was extended to 30 days, the rate increased to 4.84. Two-thirds (63.7 percent) of all visits for CS-SSI occurred within 14 days of the surgery; of those visits, 93.2 percent involved treatment in the inpatient setting.
Â
The authors note that although the overall rate of CS-SSIs was low, because of the large number of ambulatory surgical procedures performed annually, in absolute terms, a substantial number of patients develop clinically significant postoperative infections. Most of these infections occurred within two weeks after surgery and resulted in hospital admission. Our findings suggest that earlier access to a clinician or member of the surgical team (e.g., telephone check-in prior to two weeks) may help identify and treat these infections early and reduce overall morbidity.
Â
Prior studies showing significant lapses in infection control practices at ambulatory surgery centers suggest that quality improvement efforts may facilitate reducing CS-SSIs following ambulatory surgery, the authors write.
Â
This study was funded by the Agency for Healthcare Research and Quality under a contract to Truven Health Analytics to develop and support the Healthcare Cost and Utilization Project.
Source: JAMA
Barrier Against Infection: Importance and Challenges of Isolation Room Cleaning in Hospitals
October 4th 2024Isolation rooms are essential for infection control in health care, relying on specialized design, advanced cleaning protocols, and technology to prevent cross-contamination and safeguard patient safety.
Health Care Linens: An Underrecognized Risk in Infection Prevention and Control
October 2nd 2024Health care linens are critical yet overlooked infection risks. Ensure proactive management by auditing laundering processes to prevent contamination and safeguard patient health across care settings. Read this article by Alexander Sundermann, DrPH, CIC, FAPIC.
Pseudomonas aeruginosa: Infection Risks, Challenges, and Breakthroughs for Health Care Professionals
September 19th 2024Pseudomonas aeruginosa, a highly virulent pathogen, poses significant risks to immunocompromised patients, presenting challenges in treatment due to its antibiotic resistance and environmental persistence.